|
|
|
DIRECTOR
Karl
Insogna, M.D.
He is a
Professor of Medicine in the Department of Medicine (Endocrine),
and he has been at Yale for 20 years.
He is well known in the field of bone biology, and his research
interests range from basic bone cell biology to clinical research
in metabolic bone diseases. He is responsible for supervising
all the activities of the YCCMD including scientific and administrative
affairs. He, together with Dr. Gundberg, manages the Pilot
and the Feasibility Studies Program |
|
|
|
ADMINISTRATOR
Irene
Sherman
Department
of Internal Medicine
Section of Endocrinolgy
333
Cedar St. PO Box 208020
New Haven Ct. 06520- 8020
Phone
(203) 737-2871
Fax (203) 785-6462
irene.sherman@yale.edu
Yale School of Medicine
|
 |
|
|
|
CO-DIRECTOR AND CELL CORE DIRECTOR
Mark Horowitz, Ph.D.,
He is a
Professor of Orthopaedics and Rehabilitation, and he has been
at Yale for 23 years. He has been interested for nearly two decades
in the interactions among the skeletal, hematopoietic and immune
systems and is internationally recognized for his work in cytokine
biology and signal transduction and its role in bone metabolism.
|
| |
|
PILOT AND FEASABILITY PROGRAM
Dr.
Caren Gundberg,
directs the
Pilot and Feasability Program. She is a Professor in the Department
of Orthopaedics and Rehabilitation and has been at Yale for 14
years. Her research interests focus on osteocalcin, the vitamin
K-dependent protein synthesized in bone. She has an international
reputation in the development and chemistry of non-invasive measures
of bone turnover.
MOLECULAR CORE
William Philbrick,
Ph.D.,
Associate Professor of Medicine and Director of the Molecular
Core. He is a molecular and cellular biologist with extensive
experience in gene expression systems both in cultured cells and
in animal models. Bill has been actively involved in training
others in the use of the methodologies offered by the Core for
the past 15 years. He currently also serves as the Director of
the Molecular Core of the Yale Diabetes Endocrine Research Center.
|

Last
Edited
10/18/2005
JBS |
|
PHYSIOLOGY CORE
Thomas O. Carpenter, M.D., is Director of the Physiology Core. He is a pediatric endocrinologist with long-standing interest in vitamin and mineral metabolism. He has investigated the regulation of phosphate homeostasis in humans and other mammalian systems throughout his career, with particular attention to the study of clinical disorders of calcium and phosphate metabolism. He has extensive experience in cell culture studies, as well as both animal and human investigation. He has recently focused attention on magnesium's role in the acquisition of skeletal mass. He has published several important papers on the effects of magnesium depletion on bone mass in experimental animals. |